A trusted partner for your GLP-1 journey
Eat adequate total calories
This also shows that GLP-1 agonists have a role at suppressing glucagon production which allows lower postprandial and fasting glucose levels
alone, more than 110 million people are living with obesity, and by 2030, cardiometabolic diseases like obesity, diabetes and cardiovascular disease could affect one third of adults globally," says Dr
When exercise is leveraged with GLP-1, the weight loss effect is more substantial , leading to a lower risk of type 2 diabetes and cardiovascular disease
According to the TSA, Unused syringes are allowed when accompanied by injectable medication